Walgreens announced last week that it would close 160 of its VillageMD clinics after it recorded a nearly $6 billion non-cash impairment charge in the second quarter, the company said. >> Read ...
Overall, Walgreens stock looks undervalued at its current levels of around $18, irrespective of the Boots deal. It currently ...
Billionaire money managers have bought millions of shares of both Pfizer and Walgreens Boots Alliance this year.
Walgreens Boots Alliance (NYSE: WBA) stock price has become a toxic wasteland. It crashed to a low of $17 on Wednesday, much lower than its all-time high of $71.50, a 76% plunge. Its market cap ...
It’s tiny, squishy, chewy. It’s shaped like a cute baby mango and GenZers have gone crazy over it. Walgreens can’t keep it in stock. For the beleaguered drugstore chain, the odd “Gummy ...
Walgreens is launching Walgreens Specialty Pharmacy, a $24 billion business that integrates a new pharmacy equipped to handle gene and cell therapies with its existing pharmacy assets including ...
Today’s elevated interest rates, all but certain to remain higher for longer, are forcing more companies to write down goodwill impairments as the increased cost of capital weighs on the value ...
Cigna Thursday reported a $300 million first quarter loss as the company’s Evernorth health services ... [+] business grapples with the loss in value of its investment in doctor-staffed clinic ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Walgreens Specialty Pharmacy combines existing specialty assets and fully integrates AllianceRx. Effective August 1, 2024, AllianceRx Walgreens Pharmacy will become Walgreens Specialty Pharmacy.